
Privacy notice | Accessibility statement | Terms and conditions | Login | Contact |
UK data driving real-world evidence
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 4 March 2021) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 3MB, 220 pages)This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website.
“Adverse mental health outcomes in breast cancer survivors compared to women who did not have cancer: systematic review protocol”, Syst Rev, vol. 6, p. 162, 2017.
, “Adverse outcomes from initiation of systemic corticosteroids for asthma: long-term observational study”, J Asthma Allergy, vol. 11, pp. 193-204, 2018.
, “Adverse Pregnancy Outcomes Among Women with Inflammatory Bowel Disease: A Population-Based Study from England”, Inflamm Bowel Dis, vol. 22, pp. 1621-30, 2016.
, , “Adverse prognosis of incidentally detected ambulatory atrial fibrillation. A cohort study”, Thromb Haemost, vol. 112, pp. 276-86, 2014.
, “Age and sex specific antibiotic prescribing patterns in general practice in England and Wales, 1994 to 1998.”, Health Stat Q, vol. 14, pp. 14-20, 2002.
, “Age- and sex-specific antibiotic prescribing patterns in general practice in England and Wales in 1996”, Br J Gen Pract, vol. 49, pp. 735-6, 1999.
, “Age-, sex- and ethnicity-related differences in body weight, blood pressure, HbA(1c) and lipid levels at the diagnosis of type 2 diabetes relative to people without diabetes”, Diabetologia, 2020.
, “Age, sex and practice variations in the use of statins in general practice in England and Wales”, J Public Health Med, vol. 22, pp. 275-9, 2000.
, “Age-related changes in consultations and antibiotic prescribing for acute respiratory infections, 1995-2000. Data from the UK General Practice Research Database”, J Clin Pharm Ther, vol. 31, pp. 461-7, 2006.
, “Age-related decline in antibiotic prescribing for uncomplicated respiratory tract infections in primary care in England following the introduction of a national financial incentive (the Quality Premium) for health commissioners to reduce use of antibiotic”, J Antimicrob Chemother, vol. 73, pp. 2883-2892, 2018.
, “Age-related macular degeneration and complement activation-related diseases: a population-based case-control study”, Ophthalmology, vol. 115, pp. 1904-10, 2008.
, “Age-specific incidence and prevalence rates of treated epilepsy in an unselected population of 2,052,922 and age-specific fertility rates of women with epilepsy”, Lancet, vol. 352, pp. 1970-3, 1998.
, “Agreement between GPRD smoking data: a survey of general practitioners and a population-based survey”, Pharmacoepidemiol Drug Saf, vol. 13, pp. 437-41, 2004.
, “Alarm symptoms and identification of non-cancer diagnoses in primary care: cohort study”, Bmj, vol. 339, p. b3094, 2009.
, “Alarm symptoms in early diagnosis of cancer in primary care: cohort study using General Practice Research Database”, Bmj, vol. 334, p. 1040, 2007.
, “Alcohol consumption and all-cause mortality: an analysis of general practice database records for patients with long-term conditions”, J Epidemiol Community Health, vol. 71, pp. 729-735, 2017.
, “Alcohol-Related Mortality in Patients With Psoriasis: A Population-Based Cohort Study”, JAMA Dermatol, vol. 153, pp. 1256-1262, 2017.
, “Alcohol-Specific Mortality in People With Epilepsy: Cohort Studies in Two Independent Population-Based Datasets”, Front Neurol, vol. 11, p. 623139, 2020.
, “An algorithm to derive a numerical daily dose from unstructured text dosage instructions”, Pharmacoepidemiol Drug Saf, vol. 15, pp. 161-6, 2006.
, “An algorithm to identify medical practices common to both the General Practice Research Database and The Health Improvement Network database”, Pharmacoepidemiol Drug Saf, vol. 21, pp. 770-774, 2012.
, “An algorithm to identify rheumatoid arthritis in primary care: a Clinical Practice Research Datalink study”, BMJ Open, vol. 5, p. e009309, 2015.
, “An algorithm to improve diagnostic accuracy in diabetes in computerised problem orientated medical records (POMR) compared with an established algorithm developed in episode orientated records (EOMR)”, J Innov Health Inform, vol. 22, pp. 255-64, 2015.
, “Algorithms for the Capture and Adjudication of Prevalent and Incident Diabetes in UK Biobank”, PLoS One, vol. 11, p. e0162388, 2016.
, “All-cause and cardiovascular mortality in middle-aged people with type 2 diabetes compared with people without diabetes in a large U.K. primary care database”, Diabetes Care, vol. 36, pp. 2366-71, 2013.
, “All-cause mortality and vascular events among patients with rheumatoid arthritis, osteoarthritis, or no arthritis in the UK General Practice Research Database”, J Rheumatol, vol. 30, pp. 1196-202, 2003.
, “All-cause mortality in people with cirrhosis compared with the general population: a population-based cohort study”, Liver Int, vol. 32, pp. 79-84, 2012.
, “All-cause mortality rates in patients with type 1 diabetes mellitus compared with a non-diabetic population from the UK general practice research database, 1992-1999”, Diabetologia, vol. 49, pp. 660-6, 2006.
, “Allergic disease, corticosteroid use and risk of Hodgkin's lymphoma: A UK Nationwide case-control study”, J Allergy Clin Immunol, 2019.
, “Allergy, histamine 1 receptor blockers, and the risk of multiple sclerosis”, Neurology, vol. 66, pp. 572-5, 2006.
, “Allopurinol and Cardiovascular Outcomes in Adults With Hypertension”, Hypertension, vol. 67, pp. 535-40, 2016.
, “Allopurinol initiation and change in blood pressure in older adults with hypertension”, Hypertension, vol. 64, pp. 1102-7, 2014.
, “Androgen deprivation therapy and risk of acute kidney injury in patients with prostate cancer”, Jama, vol. 310, pp. 289-96, 2013.
, “Androgen Deprivation Therapy and the Incidence of Inflammatory Bowel Disease in Patients With Prostate Cancer”, Am J Epidemiol, vol. 184, pp. 15-22, 2016.
, “Androgen Deprivation Therapy and the Risk of Anemia in Men with Prostate Cancer”, Epidemiology, vol. 28, pp. 712-718, 2017.
, “Androgen deprivation therapy and the risk of colorectal cancer in patients with prostate cancer”, Cancer Causes Control, vol. 24, pp. 839-45, 2013.
, “Androgen deprivation therapy and the risk of coronary heart disease and heart failure in patients with prostate cancer: a nested case-control study in UK primary care”, Drug Saf, vol. 34, pp. 1061-77, 2011.
, “Androgen Deprivation Therapy and the Risk of Dementia in Patients With Prostate Cancer”, J Clin Oncol, vol. 35, pp. 201-207, 2017.
, “Androgen Deprivation Therapy for Prostate Cancer and the Risk of Venous Thromboembolism”, Eur Urol, vol. 70, pp. 56-61, 2016.
, “Androgen deprivation therapy for prostate cancer and the risk of hospitalisation for community-acquired pneumonia”, Thorax, vol. 72, pp. 596-597, 2017.
, “Androgen Deprivation Therapy for Prostate Cancer and the Risk of Rheumatoid Arthritis: A Population-Based Cohort Study”, Drug Saf, 2019.
, “Androgen-deprivation therapy and the risk of stroke in patients with prostate cancer”, Eur Urol, vol. 60, pp. 1244-50, 2011.
, “Angiotensin converting enzyme inhibitors and hepatocellular carcinoma incidence in the General Practice Research Database”, Cancer Causes Control, vol. 22, pp. 1743-7, 2011.
, “Angiotensin converting enzyme inhibitors and risk of lung cancer: population based cohort study”, Bmj, vol. 363, p. k4209, 2018.
, “Angiotensin receptor blocker use and gastro-oesophageal cancer survival: a population-based cohort study”, Aliment Pharmacol Ther, vol. 47, pp. 279-288, 2018.
, “Angiotensin receptor blockers and risk of cancer: cohort study among people receiving antihypertensive drugs in UK General Practice Research Database”, Bmj, vol. 344, p. e2697, 2012.
, “Angiotensin receptor blockers and risk of dementia: cohort study in UK Clinical Practice Research Datalink”, Br J Clin Pharmacol, vol. 79, pp. 337-50, 2015.
, “Angiotensin-converting enzyme inhibitor therapy and colorectal cancer risk”, J Natl Cancer Inst, vol. 106, p. djt374, 2014.
, “Angiotensin-converting enzyme inhibitor use and protection against pneumonia in patients with diabetes”, J Hypertens, vol. 25, pp. 235-9, 2007.
, “Angiotensin-converting enzyme inhibitors, calcium channel blockers, and breast cancer”, Arch Intern Med, vol. 160, pp. 349-53, 2000.
,